Swiss National Bank - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 139 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2016. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$187,000
+32.6%
40,4000.0%0.00%
Q4 2018$141,000
-65.4%
40,4000.0%0.00%
Q3 2018$407,000
+39.4%
40,4000.0%0.00%
Q2 2018$292,000
+19.7%
40,4000.0%0.00%
Q1 2018$244,000
-29.3%
40,400
+12.5%
0.00%
Q4 2017$345,000
+8.2%
35,9000.0%0.00%
Q3 2017$319,000
-29.7%
35,9000.0%0.00%
-100.0%
Q2 2017$454,000
+20.4%
35,9000.0%0.00%
Q1 2017$377,000
+14.2%
35,9000.0%0.00%
-100.0%
Q4 2016$330,000
-22.0%
35,9000.0%0.00%0.0%
Q3 2016$423,000
-18.5%
35,900
-10.5%
0.00%0.0%
Q2 2016$519,000
-24.3%
40,100
-9.5%
0.00%0.0%
Q1 2016$686,000
-34.5%
44,300
+21.0%
0.00%
-66.7%
Q4 2015$1,048,000
+0.6%
36,6000.0%0.00%0.0%
Q3 2015$1,042,000
-9.3%
36,600
+14.4%
0.00%0.0%
Q2 2015$1,149,000
+27.5%
32,000
+106.5%
0.00%
+50.0%
Q1 2015$901,000
+38.0%
15,5000.0%0.00%0.0%
Q4 2014$653,000
+14.6%
15,500
+5.4%
0.00%0.0%
Q3 2014$570,000
+24.2%
14,7000.0%0.00%0.0%
Q2 2014$459,000
+60.5%
14,700
+113.0%
0.00%
+100.0%
Q1 2014$286,000
+130.6%
6,900
+115.6%
0.00%
Q4 2013$124,0003,2000.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2016
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders